NCT02667015View on ClinicalTrials.gov

Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Other (or Unknown) Substance Use Disorders
Interventions
BEHAVIORAL

Psychotherapy (Anxiety Sensitivity Intervention)

3 week, 6-session psychotherapy targeting anxiety sensitivity

Trial Locations (1)

06061

Institute of Living/Hartford Hospital, Hartford

All Listed Sponsors
lead

Hartford Hospital

OTHER

NCT02667015 - Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity | Biotech Hunter | Biotech Hunter